Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Capital Expenditures (2020 - 2024)

iSpecimen (ISPC) has 6 years of Capital Expenditures data on record, last reported at $999546.0 in Q3 2025.

  • For Q3 2025, Capital Expenditures rose 611.9% year-over-year to $999546.0; the TTM value through Sep 2025 reached $1.0 million, up 19.64%, while the annual FY2024 figure was $31546.0, 99.16% down from the prior year.
  • Capital Expenditures reached $999546.0 in Q3 2025 per ISPC's latest filing, up from -$556547.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $3.5 million in Q3 2023 and bottomed at -$1.5 million in Q2 2023.
  • Average Capital Expenditures over 5 years is $518444.0, with a median of $339162.0 recorded in 2022.
  • Peak YoY movement for Capital Expenditures: plummeted 448.34% in 2023, then soared 611.9% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at -$211984.0 in 2021, then skyrocketed by 772.88% to $1.4 million in 2022, then tumbled by 81.34% to $266126.0 in 2023, then tumbled by 309.13% to -$556547.0 in 2024, then skyrocketed by 279.6% to $999546.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $999546.0 in Q3 2025, -$556547.0 in Q4 2024, and $140406.0 in Q3 2024.